Allergic contact dermatitis to 1,2-benzisothiazolin-3-one in the carpet industry

Australasian Journal of Dermatology

Volumn 38, Issue 1, 1997, Pages 42-43

  Taran, John M ^a   Delaney, Thomas A ^a,b  

^a FREMANTLE HOSPITAL   (Australia)

^b Glengarry Professional Centre   (Australia)

Author keywords

isothiazolinone preservatives; latex compounder; patch testing; Proxel GXL

Indexed keywords

1,2 BENZISOTHIAZOLE DERIVATIVE;

ADULT; ARTICLE; CASE REPORT; CONTACT DERMATITIS; HUMAN; MALE; OCCUPATIONAL HAZARD; PATCH TEST; SKIN ALLERGY;

EID: 0030896564     PISSN: 00048380     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-0960.1997.tb01100.x     Document Type: Article

References (6)

1. Dooms-Goosens A. Guidelines for testing with patient supplied products. Skin Research 1993; 35: 9-14.
2. Fransway AF. The problem of preservations in the 1990s (III). Agents with preservative function independent of formaldehyde release. Am. J. Contact Derm. 1991; 2: 145-74.
3. Pedersen NP. Occupational allergy from 1,2-benzisothiazolin-3-one and other preservatives in plastic emulsions. Contact Dermatitis 1976; 2: 340-2.
4. Hopkins J. Missed opportunities in clinical dermatology - the case of 1, 2-benzisothiazolin-3-one. Food Chem. Toxicol. 1994; 32: 189-91.
5. Botham PA, Hilton J, Evans CD, Lees D, Hall TJ. Assessment of the relative skin sensitizing potency of 3 biocides using the murine local lymph node assay. Contact Dermatitis 1991; 25: 172-7.
6. Damstra RJ, van Vloten WA, van Ginkel CJW. Allergic contact dermatitis from the preservative 1, 2-benzisothiazolin-3-one (1, 2-BIT, Proxel®): a case report, its prevalence in those occupationally at risk and in the general dermatological population, and its relationship to allergy to its analogue Kalton® CG. Contact Dermatitis 1992; 27: 105-9.